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(DMEM with 10% FBS containing 5 g/ml blasticidin [Invitrogen] ).
Transfection of cells
For the introduction of siRNAs, HCT116 and SW480 cells, seeded at 1.0 × 10 4 cells/ml, were incubated for 6 h and then transfected for 48-72 h with 5 nM siRNAs (Qiagen) as described above. ON-TARGET plus Non-Targeting siRNAs (Thermo Scientific) were used as negative controls. Nucleotide sequences of siRNAs used in this study are provided in Supplemental Table 5 .
The mammalian expression construct pFN21A-Halo-NEK9 was purchased from Promega. A kinase-dead mutant of NEK9 (T210A) was generated by site-directed mutagenesis using PrimeSTAR Max high-fidelity DNA polymerase (Takara). SW480 cells, seeded at 5.0 × 10 4 cells/ml in 24-well plate, were co-transfected with NEK9 siRNAs targeting the 3'UTR sequence of its mRNA (Sigma , Table S5 ) and NEK9 expression construct (encoding an siRNA-resistant NEK9 ORF) at a final concentration of 5 nM and 200 ng/ml, respectively. After incubation for 3 days, cell number was determined as described below.
Cell proliferation analysis
Cells, seeded at 2.5 × 10 4 cells/well in 24-well plates, were transfected for 48-72 h with siRNAs as described above, stained with Trypan blue, and analyzed using a Countess Automated Cell Counter (Invitrogen). For soft-agar colony formation assays, SW480 cells, seeded at 1.0 × 10 5 cells/well in 6-well plates, were transfected for 24 h with NEK9 siRNA at a final concentration of 5 nM. After detachment from the dish, 200 cells were mixed with top agarose solution consisting of 0.6% agarose in DMEM supplemented with 10% FBS, placed on a 0.7% bottom agarose layer in a 6-well plate, and then incubated for 10 days. Colonies were stained with 0.1% iodonitrotetrazolium chloride (Sigma) in methanol, photographed, and counted.
Reporter plasmid construction and luciferase assay
The 3'UTR of NEK9 mRNA was amplified by PCR from SW480 genomic DNA.
The amplified product was sub-cloned into pCR2.1 TOPO (Invitrogen) and sequenced, and subsequently cloned into pmirGLO dual-luciferase vector (Promega) to yield pmirGLO-NEK9 3'UTR. Using pmirGLO-NEK9 3'UTR plasmid as a template, site-directed mutagenesis of the miR-22 target site was performed using PrimeSTAR Max high-fidelity DNA polymerase (Takara). Primer sequences used for this study are provided in Supplementary Table 5 . For the luciferase assay, cells were transfected with either miR-22 or miR-NC for 2 days, and then 100 ng of reporter plasmid was introduced into cells using Lipofectamine 2000 (Life Technologies). After incubation for 24 h, cell extracts were prepared by addition of passive lysis buffer (Promega), and luciferase activities were measured using the Dual-Luciferase Assay Kit (Promega).
Quantitative RT-PCR
Reverse transcription was performed using Random Hexamer primers and Super Script III reverse transcriptase (Invitrogen). Synthesized cDNAs were subjected to quantitative real-time PCR (qPCR) analysis using TaqMan Universal PCR Master Mix (ABI) and gene-specific primer probe sets as indicated in Supplementary Table 5 . GAPDH was used as an internal standard.
The expression levels of mRNAs were evaluated by the comparative cycle threshold (Ct) method. Relative expression values were calculated as 2 -∆∆Ct .
Immunoblot analysis
Cells were dissolved in lysis buffer consisting of 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM MgCl 2 , 1 mM DTT, 0.5% Nonidet P-40, and 1× proteinase inhibitor cocktail (Roche). Protein concentration was quantitated by the Bradford method. Cell lysates were loaded onto 10-20% polyacrylamide gradient gels, electrophoresed, and the resolved proteins were transferred to PVDF membranes (Millipore) by a standard method. Antibodies against the following proteins were used for immunoblot analysis: CDC25B, from R&D Systems; HDAC6 (D21B10), HEXIM1, SHC1, p38 MAPK, and p21 Waf1/Cip1, from Cell Signaling Technologies; and NEK9 (M01), from ABGENT; and p53 (DO-1), from Santa Cruz Biotechnology. Horseradish peroxidase-conjugated sheep anti-mouse IgG and donkey anti-rabbit IgG (GE Healthcare) and donkey anti-goat IgG (Santa Cruz Biotechnology) were used as secondary antibodies.
Flow cytometry
Cells, seeded at 5.0 × 10 4 cells/ml in 10 cm dishes, were transfected for 72 h with NEK9 siRNAs at a final concentration of 2 or 5 nM. Transfected cells were fixed with 90% ethanol, stained with propidium iodide (Sigma) at a final concentration of 2.5 g/ml, passed through a cell-strainer filter (BD Falcon), and then subjected to flow cytometry on a Guava easyCyte (Millipore). Data were analyzed using the FlowJo software (TOMY Digital Biology Co., Ltd).
SA-β-galactosidase staining
Seven days after the introduction of NEK9 siRNA, SW480 cells were fixed with formaldehyde, and SA-β-gal activity was determined as described previously (15) . For quantitation of SA-β-gal-positive cells by flow cytometry, the culture medium of NEK9 KD cells was replaced with fresh medium containing the fluorogenic substrate C 12 FDG (Invitrogen) at a final concentration of 33 µM, and the cells were incubated for 2 h (20). After washing, cells were re-suspended in 1 ml PBS, passed through a cell-strainer filter (BD Falcon), and analyzed on an EC800 Flow Cytometry Analyzer (SONY Biotechnology Inc.).
Statistical analyses
We conducted statistical analyses by two-tailed unpaired Student's t-test. Clinical sample data were analyzed by one-tailed unpaired Student's test.
Significance of overall survival (OS) was estimated by Wilcoxon test. p < 0.05 was considered statistically significant.
Supplementary Figure Legends

Supplementary Figure 1
Strategy for miR-22 target screening assay. Genes down-regulated in both SW480 (p53 mutant) and HCT116 p53 -/cells in the presence of miR-22 were selected (first selection).
The fold changes were compared to those in HCT116 cells, and genes exhibiting a differential response to miR-22 were selected (second selection). From among the resultant genes, those classified as encoding cell-cycle regulators in the Gene Ontology database were selected (third selection). Finally, potential miR-22 targets were identified by in silico analysis using the miRWalk database (fourth selection). The number of genes selected at each step is shown to the right of the flow chart. Supplementary Fig. 3B   Supplementary Fig. 3A 
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